Graz, Germany

Fred Lembeck

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fred Lembeck. Retrieved from https://idiyas.com/inventor/fred-lembeck-01x8vhgs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fred Lembeck: Innovator in Virus Disease Treatment

Introduction

Fred Lembeck is a notable inventor based in Graz, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of virus diseases. His innovative work has led to the development of a patent that addresses critical health challenges.

Latest Patents

Fred Lembeck holds a patent for "Bradykinin antagonists for the prophylaxis or treatment of virus diseases." This patent highlights the use of Bradykinin antagonists and their physiologically tolerated salts as effective treatments for virus diseases. His work in this area is crucial for advancing therapeutic options available to patients.

Career Highlights

Lembeck's career is marked by his association with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His role at Hoechst has allowed him to focus on innovative research and development, contributing to the advancement of medical science.

Collaborations

Throughout his career, Fred Lembeck has collaborated with esteemed colleagues, including Klaus Wirth and Irvin Winkler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Fred Lembeck's contributions to the field of medicine through his patent and collaborations underscore his importance as an inventor. His work continues to influence the treatment of virus diseases, showcasing the impact of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…